nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—AOC3—endothelium—systemic scleroderma	0.0377	0.16	CbGeAlD
Hydralazine—AOC3—blood vessel—systemic scleroderma	0.0348	0.147	CbGeAlD
Hydralazine—RYR2—smooth muscle tissue—systemic scleroderma	0.0271	0.115	CbGeAlD
Hydralazine—RYR2—lung—systemic scleroderma	0.0179	0.0757	CbGeAlD
Hydralazine—AOC3—connective tissue—systemic scleroderma	0.0178	0.0756	CbGeAlD
Hydralazine—AOC3—smooth muscle tissue—systemic scleroderma	0.0163	0.0691	CbGeAlD
Hydralazine—P4HA1—connective tissue—systemic scleroderma	0.0142	0.0604	CbGeAlD
Hydralazine—P4HA1—smooth muscle tissue—systemic scleroderma	0.013	0.0553	CbGeAlD
Hydralazine—AOC3—digestive system—systemic scleroderma	0.0129	0.0546	CbGeAlD
Hydralazine—AOC3—tendon—systemic scleroderma	0.0122	0.052	CbGeAlD
Hydralazine—AOC3—lung—systemic scleroderma	0.0107	0.0456	CbGeAlD
Hydralazine—P4HA1—tendon—systemic scleroderma	0.00979	0.0415	CbGeAlD
Hydralazine—P4HA1—lung—systemic scleroderma	0.00859	0.0364	CbGeAlD
Hydralazine—CYP3A4—digestive system—systemic scleroderma	0.00273	0.0116	CbGeAlD
Hydralazine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00155	0.00202	CcSEcCtD
Hydralazine—Purpura—Prednisone—systemic scleroderma	0.00154	0.00202	CcSEcCtD
Hydralazine—Agitation—Mycophenolic acid—systemic scleroderma	0.00154	0.00201	CcSEcCtD
Hydralazine—Dyspepsia—Captopril—systemic scleroderma	0.00153	0.002	CcSEcCtD
Hydralazine—Cardiac failure—Prednisone—systemic scleroderma	0.00152	0.00199	CcSEcCtD
Hydralazine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00198	CcSEcCtD
Hydralazine—Dizziness—Pentoxifylline—systemic scleroderma	0.00152	0.00198	CcSEcCtD
Hydralazine—Decreased appetite—Captopril—systemic scleroderma	0.00151	0.00198	CcSEcCtD
Hydralazine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00197	CcSEcCtD
Hydralazine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00197	CcSEcCtD
Hydralazine—Malaise—Mycophenolic acid—systemic scleroderma	0.00151	0.00197	CcSEcCtD
Hydralazine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.0015	0.00196	CcSEcCtD
Hydralazine—Arthralgia—Leflunomide—systemic scleroderma	0.00149	0.00195	CcSEcCtD
Hydralazine—Myalgia—Leflunomide—systemic scleroderma	0.00149	0.00195	CcSEcCtD
Hydralazine—Anxiety—Leflunomide—systemic scleroderma	0.00149	0.00195	CcSEcCtD
Hydralazine—Constipation—Captopril—systemic scleroderma	0.00149	0.00194	CcSEcCtD
Hydralazine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00148	0.00194	CcSEcCtD
Hydralazine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00148	0.00193	CcSEcCtD
Hydralazine—Discomfort—Leflunomide—systemic scleroderma	0.00148	0.00193	CcSEcCtD
Hydralazine—Vomiting—Pentoxifylline—systemic scleroderma	0.00146	0.00191	CcSEcCtD
Hydralazine—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00146	0.0019	CcSEcCtD
Hydralazine—Psychotic disorder—Prednisone—systemic scleroderma	0.00145	0.0019	CcSEcCtD
Hydralazine—Muscle spasms—Lisinopril—systemic scleroderma	0.00145	0.0019	CcSEcCtD
Hydralazine—Rash—Pentoxifylline—systemic scleroderma	0.00144	0.00189	CcSEcCtD
Hydralazine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00144	0.00189	CcSEcCtD
Hydralazine—Headache—Pentoxifylline—systemic scleroderma	0.00144	0.00188	CcSEcCtD
Hydralazine—Feeling abnormal—Captopril—systemic scleroderma	0.00143	0.00187	CcSEcCtD
Hydralazine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00142	0.00186	CcSEcCtD
Hydralazine—Myalgia—Mycophenolic acid—systemic scleroderma	0.00142	0.00186	CcSEcCtD
Hydralazine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00142	0.00186	CcSEcCtD
Hydralazine—Hypotension—Azathioprine—systemic scleroderma	0.00142	0.00185	CcSEcCtD
Hydralazine—Tremor—Lisinopril—systemic scleroderma	0.00141	0.00185	CcSEcCtD
Hydralazine—Discomfort—Mycophenolic acid—systemic scleroderma	0.00141	0.00184	CcSEcCtD
Hydralazine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.0014	0.00183	CcSEcCtD
Hydralazine—Pruritus—Mometasone—systemic scleroderma	0.0014	0.00183	CcSEcCtD
Hydralazine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.0014	0.00183	CcSEcCtD
Hydralazine—Tachycardia—Leflunomide—systemic scleroderma	0.0014	0.00183	CcSEcCtD
Hydralazine—Anaemia—Lisinopril—systemic scleroderma	0.00139	0.00182	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00138	0.00181	CcSEcCtD
Hydralazine—Body temperature increased—Captopril—systemic scleroderma	0.00137	0.0018	CcSEcCtD
Hydralazine—Oedema—Mycophenolic acid—systemic scleroderma	0.00137	0.00179	CcSEcCtD
Hydralazine—Anorexia—Leflunomide—systemic scleroderma	0.00136	0.00179	CcSEcCtD
Hydralazine—Nausea—Pentoxifylline—systemic scleroderma	0.00136	0.00178	CcSEcCtD
Hydralazine—Chills—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00178	CcSEcCtD
Hydralazine—Malaise—Lisinopril—systemic scleroderma	0.00136	0.00178	CcSEcCtD
Hydralazine—Diarrhoea—Mometasone—systemic scleroderma	0.00135	0.00177	CcSEcCtD
Hydralazine—Leukopenia—Lisinopril—systemic scleroderma	0.00135	0.00176	CcSEcCtD
Hydralazine—Renal failure acute—Methotrexate—systemic scleroderma	0.00135	0.00176	CcSEcCtD
Hydralazine—Hypotension—Leflunomide—systemic scleroderma	0.00134	0.00175	CcSEcCtD
Hydralazine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00134	0.00175	CcSEcCtD
Hydralazine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00133	0.00174	CcSEcCtD
Hydralazine—Palpitations—Lisinopril—systemic scleroderma	0.00133	0.00174	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00131	0.00171	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.0013	0.00171	CcSEcCtD
Hydralazine—Anorexia—Mycophenolic acid—systemic scleroderma	0.0013	0.0017	CcSEcCtD
Hydralazine—Paraesthesia—Leflunomide—systemic scleroderma	0.00129	0.00168	CcSEcCtD
Hydralazine—Myalgia—Lisinopril—systemic scleroderma	0.00128	0.00168	CcSEcCtD
Hydralazine—Arthralgia—Lisinopril—systemic scleroderma	0.00128	0.00168	CcSEcCtD
Hydralazine—Anxiety—Lisinopril—systemic scleroderma	0.00128	0.00167	CcSEcCtD
Hydralazine—Dyspnoea—Leflunomide—systemic scleroderma	0.00128	0.00167	CcSEcCtD
Hydralazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00128	0.00167	CcSEcCtD
Hydralazine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00166	CcSEcCtD
Hydralazine—Discomfort—Lisinopril—systemic scleroderma	0.00127	0.00166	CcSEcCtD
Hydralazine—Dyspepsia—Leflunomide—systemic scleroderma	0.00126	0.00165	CcSEcCtD
Hydralazine—Vomiting—Mometasone—systemic scleroderma	0.00126	0.00164	CcSEcCtD
Hydralazine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00125	0.00163	CcSEcCtD
Hydralazine—Rash—Mometasone—systemic scleroderma	0.00125	0.00163	CcSEcCtD
Hydralazine—Dermatitis—Mometasone—systemic scleroderma	0.00125	0.00163	CcSEcCtD
Hydralazine—Decreased appetite—Leflunomide—systemic scleroderma	0.00124	0.00163	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00124	0.00163	CcSEcCtD
Hydralazine—Headache—Mometasone—systemic scleroderma	0.00124	0.00162	CcSEcCtD
Hydralazine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00162	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00124	0.00162	CcSEcCtD
Hydralazine—Oedema—Lisinopril—systemic scleroderma	0.00123	0.00161	CcSEcCtD
Hydralazine—Pruritus—Captopril—systemic scleroderma	0.00123	0.00161	CcSEcCtD
Hydralazine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00123	0.0016	CcSEcCtD
Hydralazine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00123	0.0016	CcSEcCtD
Hydralazine—Constipation—Leflunomide—systemic scleroderma	0.00122	0.0016	CcSEcCtD
Hydralazine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.0016	CcSEcCtD
Hydralazine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00122	0.00159	CcSEcCtD
Hydralazine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00159	CcSEcCtD
Hydralazine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0012	0.00158	CcSEcCtD
Hydralazine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.0012	0.00157	CcSEcCtD
Hydralazine—Neutropenia—Prednisone—systemic scleroderma	0.0012	0.00157	CcSEcCtD
Hydralazine—Tachycardia—Lisinopril—systemic scleroderma	0.0012	0.00157	CcSEcCtD
Hydralazine—Body temperature increased—Azathioprine—systemic scleroderma	0.0012	0.00157	CcSEcCtD
Hydralazine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00156	CcSEcCtD
Hydralazine—Diarrhoea—Captopril—systemic scleroderma	0.00119	0.00155	CcSEcCtD
Hydralazine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00119	0.00155	CcSEcCtD
Hydralazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00155	CcSEcCtD
Hydralazine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00118	0.00154	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00118	0.00154	CcSEcCtD
Hydralazine—Nausea—Mometasone—systemic scleroderma	0.00117	0.00154	CcSEcCtD
Hydralazine—Anorexia—Lisinopril—systemic scleroderma	0.00117	0.00153	CcSEcCtD
Hydralazine—Constipation—Mycophenolic acid—systemic scleroderma	0.00117	0.00153	CcSEcCtD
Hydralazine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00153	CcSEcCtD
Hydralazine—Weight decreased—Prednisone—systemic scleroderma	0.00116	0.00152	CcSEcCtD
Hydralazine—Hypotension—Lisinopril—systemic scleroderma	0.00115	0.0015	CcSEcCtD
Hydralazine—Dizziness—Captopril—systemic scleroderma	0.00115	0.0015	CcSEcCtD
Hydralazine—Depression—Prednisone—systemic scleroderma	0.00114	0.00149	CcSEcCtD
Hydralazine—Urticaria—Leflunomide—systemic scleroderma	0.00114	0.00149	CcSEcCtD
Hydralazine—Body temperature increased—Leflunomide—systemic scleroderma	0.00113	0.00148	CcSEcCtD
Hydralazine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00113	0.00147	CcSEcCtD
Hydralazine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00147	CcSEcCtD
Hydralazine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00147	CcSEcCtD
Hydralazine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00112	0.00147	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00112	0.00147	CcSEcCtD
Hydralazine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00147	CcSEcCtD
Hydralazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00112	0.00146	CcSEcCtD
Hydralazine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00145	CcSEcCtD
Hydralazine—Paraesthesia—Lisinopril—systemic scleroderma	0.0011	0.00144	CcSEcCtD
Hydralazine—Vomiting—Captopril—systemic scleroderma	0.0011	0.00144	CcSEcCtD
Hydralazine—Dyspnoea—Lisinopril—systemic scleroderma	0.0011	0.00143	CcSEcCtD
Hydralazine—Rash—Captopril—systemic scleroderma	0.00109	0.00143	CcSEcCtD
Hydralazine—Dermatitis—Captopril—systemic scleroderma	0.00109	0.00143	CcSEcCtD
Hydralazine—Headache—Captopril—systemic scleroderma	0.00109	0.00142	CcSEcCtD
Hydralazine—Dyspepsia—Lisinopril—systemic scleroderma	0.00108	0.00142	CcSEcCtD
Hydralazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00108	0.00141	CcSEcCtD
Hydralazine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00141	CcSEcCtD
Hydralazine—Decreased appetite—Lisinopril—systemic scleroderma	0.00107	0.0014	CcSEcCtD
Hydralazine—Eosinophilia—Methotrexate—systemic scleroderma	0.00106	0.00139	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00106	0.00139	CcSEcCtD
Hydralazine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00138	CcSEcCtD
Hydralazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00105	0.00138	CcSEcCtD
Hydralazine—Constipation—Lisinopril—systemic scleroderma	0.00105	0.00138	CcSEcCtD
Hydralazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00138	CcSEcCtD
Hydralazine—Diarrhoea—Azathioprine—systemic scleroderma	0.00104	0.00136	CcSEcCtD
Hydralazine—Nausea—Captopril—systemic scleroderma	0.00103	0.00135	CcSEcCtD
Hydralazine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00134	CcSEcCtD
Hydralazine—Hallucination—Prednisone—systemic scleroderma	0.00102	0.00134	CcSEcCtD
Hydralazine—Pancytopenia—Methotrexate—systemic scleroderma	0.00102	0.00133	CcSEcCtD
Hydralazine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00101	0.00133	CcSEcCtD
Hydralazine—Pruritus—Leflunomide—systemic scleroderma	0.00101	0.00132	CcSEcCtD
Hydralazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00132	CcSEcCtD
Hydralazine—Dysuria—Methotrexate—systemic scleroderma	0.001	0.00131	CcSEcCtD
Hydralazine—Neutropenia—Methotrexate—systemic scleroderma	0.001	0.00131	CcSEcCtD
Hydralazine—Dizziness—Azathioprine—systemic scleroderma	0.001	0.00131	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000982	0.00128	CcSEcCtD
Hydralazine—Diarrhoea—Leflunomide—systemic scleroderma	0.000979	0.00128	CcSEcCtD
Hydralazine—Urticaria—Lisinopril—systemic scleroderma	0.000977	0.00128	CcSEcCtD
Hydralazine—Body temperature increased—Lisinopril—systemic scleroderma	0.000972	0.00127	CcSEcCtD
Hydralazine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000968	0.00127	CcSEcCtD
Hydralazine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000966	0.00126	CcSEcCtD
Hydralazine—Vomiting—Azathioprine—systemic scleroderma	0.000964	0.00126	CcSEcCtD
Hydralazine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000961	0.00126	CcSEcCtD
Hydralazine—Rash—Azathioprine—systemic scleroderma	0.000956	0.00125	CcSEcCtD
Hydralazine—Dermatitis—Azathioprine—systemic scleroderma	0.000955	0.00125	CcSEcCtD
Hydralazine—Depression—Methotrexate—systemic scleroderma	0.000954	0.00125	CcSEcCtD
Hydralazine—Flushing—Prednisone—systemic scleroderma	0.000954	0.00125	CcSEcCtD
Hydralazine—Headache—Azathioprine—systemic scleroderma	0.000949	0.00124	CcSEcCtD
Hydralazine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000948	0.00124	CcSEcCtD
Hydralazine—Dizziness—Leflunomide—systemic scleroderma	0.000946	0.00124	CcSEcCtD
Hydralazine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000937	0.00123	CcSEcCtD
Hydralazine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000934	0.00122	CcSEcCtD
Hydralazine—Conjunctivitis—Methotrexate—systemic scleroderma	0.00093	0.00122	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00093	0.00122	CcSEcCtD
Hydralazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000921	0.00121	CcSEcCtD
Hydralazine—Haematuria—Methotrexate—systemic scleroderma	0.000913	0.00119	CcSEcCtD
Hydralazine—Vomiting—Leflunomide—systemic scleroderma	0.00091	0.00119	CcSEcCtD
Hydralazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000906	0.00119	CcSEcCtD
Hydralazine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000903	0.00118	CcSEcCtD
Hydralazine—Rash—Leflunomide—systemic scleroderma	0.000902	0.00118	CcSEcCtD
Hydralazine—Dermatitis—Leflunomide—systemic scleroderma	0.000902	0.00118	CcSEcCtD
Hydralazine—Nausea—Azathioprine—systemic scleroderma	0.0009	0.00118	CcSEcCtD
Hydralazine—Headache—Leflunomide—systemic scleroderma	0.000897	0.00117	CcSEcCtD
Hydralazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000893	0.00117	CcSEcCtD
Hydralazine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000888	0.00116	CcSEcCtD
Hydralazine—Pruritus—Lisinopril—systemic scleroderma	0.00087	0.00114	CcSEcCtD
Hydralazine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000868	0.00114	CcSEcCtD
Hydralazine—Rash—Mycophenolic acid—systemic scleroderma	0.000861	0.00113	CcSEcCtD
Hydralazine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00086	0.00113	CcSEcCtD
Hydralazine—Hepatitis—Methotrexate—systemic scleroderma	0.000859	0.00112	CcSEcCtD
Hydralazine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000856	0.00112	CcSEcCtD
Hydralazine—Headache—Mycophenolic acid—systemic scleroderma	0.000855	0.00112	CcSEcCtD
Hydralazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000852	0.00111	CcSEcCtD
Hydralazine—Nausea—Leflunomide—systemic scleroderma	0.00085	0.00111	CcSEcCtD
Hydralazine—Diarrhoea—Lisinopril—systemic scleroderma	0.000841	0.0011	CcSEcCtD
Hydralazine—Ill-defined disorder—Prednisone—systemic scleroderma	0.00083	0.00109	CcSEcCtD
Hydralazine—Anaemia—Prednisone—systemic scleroderma	0.000827	0.00108	CcSEcCtD
Hydralazine—Agitation—Prednisone—systemic scleroderma	0.000822	0.00108	CcSEcCtD
Hydralazine—Dizziness—Lisinopril—systemic scleroderma	0.000813	0.00106	CcSEcCtD
Hydralazine—Nausea—Mycophenolic acid—systemic scleroderma	0.000811	0.00106	CcSEcCtD
Hydralazine—Malaise—Prednisone—systemic scleroderma	0.000807	0.00106	CcSEcCtD
Hydralazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000794	0.00104	CcSEcCtD
Hydralazine—Vomiting—Lisinopril—systemic scleroderma	0.000782	0.00102	CcSEcCtD
Hydralazine—Rash—Lisinopril—systemic scleroderma	0.000775	0.00101	CcSEcCtD
Hydralazine—Dermatitis—Lisinopril—systemic scleroderma	0.000775	0.00101	CcSEcCtD
Hydralazine—Chills—Methotrexate—systemic scleroderma	0.000771	0.00101	CcSEcCtD
Hydralazine—Headache—Lisinopril—systemic scleroderma	0.00077	0.00101	CcSEcCtD
Hydralazine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000762	0.000998	CcSEcCtD
Hydralazine—Myalgia—Prednisone—systemic scleroderma	0.000762	0.000997	CcSEcCtD
Hydralazine—Arthralgia—Prednisone—systemic scleroderma	0.000762	0.000997	CcSEcCtD
Hydralazine—Anxiety—Prednisone—systemic scleroderma	0.000759	0.000994	CcSEcCtD
Hydralazine—Discomfort—Prednisone—systemic scleroderma	0.000753	0.000985	CcSEcCtD
Hydralazine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000737	0.000965	CcSEcCtD
Hydralazine—Nausea—Lisinopril—systemic scleroderma	0.00073	0.000956	CcSEcCtD
Hydralazine—Oedema—Prednisone—systemic scleroderma	0.00073	0.000956	CcSEcCtD
Hydralazine—Tachycardia—Prednisone—systemic scleroderma	0.000713	0.000933	CcSEcCtD
Hydralazine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000713	0.000932	CcSEcCtD
Hydralazine—Anorexia—Prednisone—systemic scleroderma	0.000696	0.000911	CcSEcCtD
Hydralazine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000694	0.000908	CcSEcCtD
Hydralazine—Anaemia—Methotrexate—systemic scleroderma	0.000691	0.000905	CcSEcCtD
Hydralazine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000685	0.000896	CcSEcCtD
Hydralazine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000679	0.000889	CcSEcCtD
Hydralazine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000679	0.000888	CcSEcCtD
Hydralazine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000675	0.000883	CcSEcCtD
Hydralazine—Malaise—Methotrexate—systemic scleroderma	0.000674	0.000883	CcSEcCtD
Hydralazine—Leukopenia—Methotrexate—systemic scleroderma	0.000669	0.000876	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000665	0.000871	CcSEcCtD
Hydralazine—Paraesthesia—Prednisone—systemic scleroderma	0.000656	0.000858	CcSEcCtD
Hydralazine—Dyspepsia—Prednisone—systemic scleroderma	0.000643	0.000841	CcSEcCtD
Hydralazine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00064	0.000837	CcSEcCtD
Hydralazine—Myalgia—Methotrexate—systemic scleroderma	0.000637	0.000833	CcSEcCtD
Hydralazine—Arthralgia—Methotrexate—systemic scleroderma	0.000637	0.000833	CcSEcCtD
Hydralazine—Decreased appetite—Prednisone—systemic scleroderma	0.000635	0.000831	CcSEcCtD
Hydralazine—Discomfort—Methotrexate—systemic scleroderma	0.000629	0.000823	CcSEcCtD
Hydralazine—Constipation—Prednisone—systemic scleroderma	0.000625	0.000817	CcSEcCtD
Hydralazine—Feeling abnormal—Prednisone—systemic scleroderma	0.000602	0.000788	CcSEcCtD
Hydralazine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000598	0.000782	CcSEcCtD
Hydralazine—Anorexia—Methotrexate—systemic scleroderma	0.000582	0.000761	CcSEcCtD
Hydralazine—Urticaria—Prednisone—systemic scleroderma	0.00058	0.000759	CcSEcCtD
Hydralazine—Body temperature increased—Prednisone—systemic scleroderma	0.000577	0.000756	CcSEcCtD
Hydralazine—Hypotension—Methotrexate—systemic scleroderma	0.00057	0.000746	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000556	0.000728	CcSEcCtD
Hydralazine—Paraesthesia—Methotrexate—systemic scleroderma	0.000548	0.000717	CcSEcCtD
Hydralazine—Dyspnoea—Methotrexate—systemic scleroderma	0.000544	0.000712	CcSEcCtD
Hydralazine—Hypersensitivity—Prednisone—systemic scleroderma	0.000538	0.000704	CcSEcCtD
Hydralazine—Dyspepsia—Methotrexate—systemic scleroderma	0.000537	0.000703	CcSEcCtD
Hydralazine—Decreased appetite—Methotrexate—systemic scleroderma	0.000531	0.000694	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000527	0.00069	CcSEcCtD
Hydralazine—Pruritus—Prednisone—systemic scleroderma	0.000517	0.000676	CcSEcCtD
Hydralazine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000503	0.000658	CcSEcCtD
Hydralazine—Diarrhoea—Prednisone—systemic scleroderma	0.0005	0.000654	CcSEcCtD
Hydralazine—Urticaria—Methotrexate—systemic scleroderma	0.000485	0.000635	CcSEcCtD
Hydralazine—Dizziness—Prednisone—systemic scleroderma	0.000483	0.000632	CcSEcCtD
Hydralazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000483	0.000631	CcSEcCtD
Hydralazine—Vomiting—Prednisone—systemic scleroderma	0.000464	0.000608	CcSEcCtD
Hydralazine—Rash—Prednisone—systemic scleroderma	0.000461	0.000603	CcSEcCtD
Hydralazine—Dermatitis—Prednisone—systemic scleroderma	0.00046	0.000602	CcSEcCtD
Hydralazine—Headache—Prednisone—systemic scleroderma	0.000458	0.000599	CcSEcCtD
Hydralazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00045	0.000588	CcSEcCtD
Hydralazine—Nausea—Prednisone—systemic scleroderma	0.000434	0.000568	CcSEcCtD
Hydralazine—Pruritus—Methotrexate—systemic scleroderma	0.000432	0.000565	CcSEcCtD
Hydralazine—Diarrhoea—Methotrexate—systemic scleroderma	0.000418	0.000546	CcSEcCtD
Hydralazine—Dizziness—Methotrexate—systemic scleroderma	0.000404	0.000528	CcSEcCtD
Hydralazine—Vomiting—Methotrexate—systemic scleroderma	0.000388	0.000508	CcSEcCtD
Hydralazine—Rash—Methotrexate—systemic scleroderma	0.000385	0.000504	CcSEcCtD
Hydralazine—Dermatitis—Methotrexate—systemic scleroderma	0.000385	0.000503	CcSEcCtD
Hydralazine—Headache—Methotrexate—systemic scleroderma	0.000382	0.0005	CcSEcCtD
Hydralazine—Nausea—Methotrexate—systemic scleroderma	0.000363	0.000474	CcSEcCtD
